» Articles » PMID: 37699627

Exploring COVID-19 Vaccine Hesitancy and Uptake in Nairobi's Urban Informal Settlements: an Unsupervised Machine Learning Analysis of a Longitudinal Prospective Cohort Study from 2021 to 2022

Overview
Journal BMJ Open
Specialty General Medicine
Date 2023 Sep 12
PMID 37699627
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To illustrate the utility of unsupervised machine learning compared with traditional methods of analysis by identifying archetypes within the population that may be more or less likely to get the COVID-19 vaccine.

Design: A longitudinal prospective cohort study (n=2009 households) with recurring phone surveys from 2020 to 2022 to assess COVID-19 knowledge, attitudes and practices. Vaccine questions were added in 2021 (n=1117) and 2022 (n=1121) rounds.

Setting: Five informal settlements in Nairobi, Kenya.

Participants: Individuals from 2009 households included.

Outcome Measures And Analysis: Respondents were asked about COVID-19 vaccine acceptance (February 2021) and vaccine uptake (March 2022). Three distinct clusters were estimated using K-Means clustering and analysed against vaccine acceptance and vaccine uptake outcomes using regression forest analysis.

Results: Despite higher educational attainment and fewer concerns regarding the pandemic, young adults (cluster 3) were less likely to intend to get the vaccine compared with cluster 1 (41.5% vs 55.3%, respectively; p<0.01). Despite believing certain COVID-19 myths, older adults with larger households and more fears regarding economic impacts of the pandemic (cluster 1) were more likely to ultimately to get vaccinated than cluster 3 (78% vs 66.4%; p<0.01), potentially due to employment requirements. Middle-aged women who are married or divorced and reported higher risk of gender-based violence in the home (cluster 2) were more likely than young adults (cluster 3) to report wanting to get the vaccine (50.5% vs 41.5%; p=0.014) but not more likely to have gotten it (69.3% vs 66.4%; p=0.41), indicating potential gaps in access and broader need for social support for this group.

Conclusions: Findings suggest this methodology can be a useful tool to characterise populations, with utility for improving targeted policy, programmes and behavioural messaging to promote uptake of healthy behaviours and ensure equitable distribution of prevention measures.

Citing Articles

EMSIG: Uncovering Factors Influencing COVID-19 Vaccination Across Different Subgroups Characterized by Embedding-Based Spatial Information Gain.

Yue Z, McCormick N, Ezeala O, Durham S, Westrick S Vaccines (Basel). 2024; 12(11).

PMID: 39591156 PMC: 11599077. DOI: 10.3390/vaccines12111253.


Gendered socio-economic and mental health effects of the COVID-19 pandemic among adults living in selected informal settlements in Kenya: an intersectional analysis.

Mwanga D, Odero H, Kadengye D, Odunga S, Muluve E, Mugotitsa B Front Public Health. 2024; 12:1469091.

PMID: 39534737 PMC: 11554471. DOI: 10.3389/fpubh.2024.1469091.


Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis.

Alie M, Abebe G, Negesse Y, Adugna A, Girma D BMC Public Health. 2024; 24(1):2796.

PMID: 39395943 PMC: 11470748. DOI: 10.1186/s12889-024-20324-z.

References
1.
Coccia M . Sources, diffusion and prediction in COVID-19 pandemic: lessons learned to face next health emergency. AIMS Public Health. 2023; 10(1):145-168. PMC: 10091135. DOI: 10.3934/publichealth.2023012. View

2.
Osur J, Muinga E, Carter J, Kuria S, Hussein S, Ireri E . COVID-19 vaccine hesitancy: Vaccination intention and attitudes of community health volunteers in Kenya. PLOS Glob Public Health. 2023; 2(3):e0000233. PMC: 10021929. DOI: 10.1371/journal.pgph.0000233. View

3.
Wenham C, Smith J, Morgan R . COVID-19: the gendered impacts of the outbreak. Lancet. 2020; 395(10227):846-848. PMC: 7124625. DOI: 10.1016/S0140-6736(20)30526-2. View

4.
Stanturf J, Goodrick S, Warren Jr M, Charnley S, Stegall C . Social Vulnerability and Ebola Virus Disease in Rural Liberia. PLoS One. 2015; 10(9):e0137208. PMC: 4556488. DOI: 10.1371/journal.pone.0137208. View

5.
Coccia M . Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis. Environ Res. 2021; 204(Pt C):112314. PMC: 8560189. DOI: 10.1016/j.envres.2021.112314. View